NFGH
Nan Fung Group Holdings Portfolio holdings
AUM
$63.4M
This Quarter Return
+20.7%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
–
10 Year Return
–
AUM
$108M
AUM Growth
+$108M
(-33%)
Cap. Flow
-$60M
Cap. Flow
% of AUM
-55.6%
Top 10 Holdings %
Top 10 Hldgs %
66.44%
Holding
50
New
11
Increased
11
Reduced
4
Closed
5
Top Buys
| 1 |
Standard BioTools
LAB
|
$5.1M |
| 2 |
LBPH
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
|
$2.55M |
| 3 |
Incyte
INCY
|
$2.39M |
| 4 |
Ascendis Pharma
ASND
|
$2.06M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.72M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$71.4M |
| 2 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$4.29M |
| 3 |
Merus
MRUS
|
$2.14M |
| 4 |
AFMD
Affimed
AFMD
|
$1.78M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$1.01M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Illumina
ILMN
$15.8B
| $16.4M | 15.17% |
119,196
| – | – |
|
2
Harmony Biosciences
HRMY
$2.12B
| $12.4M | 11.47% |
368,665
| – | – |
|
|
ALPN
3
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $10.5M | 9.69% |
263,940
| – | – |
|
4
Oculis Holding
OCS
$844M
| $5.26M | 4.87% |
436,378
-82,555
| -16% | -$995K |
|
|
5
Standard BioTools
LAB
$481M
| $5.1M | 4.73% |
+1,883,179
| New | +$5.1M |
|
|
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $4.92M | 4.56% |
859,892
| – | – |
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $4.59M | 4.26% |
106,680
| – | – |
|
8
Geron
GERN
$893M
| $4.37M | 4.05% |
1,324,550
+411,000
| +45% | +$1.36M |
|
|
9
Incyte
INCY
$16.5B
| $4.22M | 3.91% |
74,022
+42,000
| +131% | +$2.39M |
|
|
10
Merus
MRUS
$4.98B
| $4.03M | 3.74% |
89,516
-47,522
| -35% | -$2.14M |
|
|
ONC
11
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.6M | 3.34% |
23,022
+11,000
| +91% | +$1.72M |
|
|
12
KalVista Pharmaceuticals
KALV
$678M
| $2.6M | 2.41% |
219,277
-85,000
| -28% | -$1.01M |
|
|
LBPH
13
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.55M | 2.37% |
+118,255
| New | +$2.55M |
|
14
Mirum Pharmaceuticals
MIRM
$3.71B
| $2.41M | 2.24% |
96,100
| – | – |
|
15
Rhythm Pharmaceuticals
RYTM
$6.85B
| $2.13M | 1.97% |
49,120
+9,050
| +23% | +$392K |
|
|
16
Ascendis Pharma
ASND
$11.8B
| $2.06M | 1.91% |
+13,600
| New | +$2.06M |
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.9M | 1.76% |
102,984
+73,000
| +243% | +$1.35M |
|
18
Replimune Group
REPL
$422M
| $1.67M | 1.55% |
204,939
+20,200
| +11% | +$165K |
|
19
Bolt Biotherapeutics
BOLT
$9.85M
| $1.63M | 1.51% |
1,166,952
| – | – |
|
20
Rani Therapeutics
RANI
$24.4M
| $1.54M | 1.42% |
493,584
| – | – |
|
21
Exelixis
EXEL
$10.1B
| $1.52M | 1.41% |
64,200
| – | – |
|
22
Madrigal Pharmaceuticals
MDGL
$9.76B
| $1.52M | 1.41% |
5,682
+4,500
| +381% | +$1.2M |
|
|
JBIO
23
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $1.42M | 1.31% |
47,936
| – | – |
|
24
Pacific Biosciences
PACB
$393M
| $1.03M | 0.95% |
274,488
| – | – |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $945K | 0.88% |
10,815
+7,200
| +199% | +$629K |
|